Giovanni Zuliani Selected Research

Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)

1/2022	Acetyl-cholinesterase-inhibitors slow cognitive decline and decrease overall mortality in older patients with dementia.
8/2021	Serum Apo J as a potential marker of conversion from mild cognitive impairment to dementia.
5/2020	Arylesterase Activity of Paraoxonase-1 in Serum and Cerebrospinal Fluid of Patients with Alzheimer's Disease and Vascular Dementia.
1/2018	Gene-gene interactions among coding genes of iron-homeostasis proteins and APOE-alleles in cognitive impairment diseases.
12/2016	Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases.
10/2015	Serum paraoxonase and arylesterase activities of paraoxonase-1 (PON-1), mild cognitive impairment, and 2-year conversion to dementia: A pilot study.
6/2015	PON-1 and ferroxidase activities in older patients with mild cognitive impairment, late onset Alzheimer's disease or vascular dementia.
3/2015	Brain-derived neurotrophic factor plasma levels: relationship with dementia and diabetes in the elderly population.
2/2014	Oxidative balance, homocysteine, and uric acid levels in older patients with Late Onset Alzheimer's Disease or Vascular Dementia.
10/2011	Plasma 24S-hydroxycholesterol levels in elderly subjects with late onset Alzheimer's disease or vascular dementia: a case-control study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giovanni Zuliani Research Topics

Disease

23	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 03/2008
19	Dementia (Dementias) 07/2022 - 12/2004
15	Cognitive Dysfunction 01/2022 - 05/2007
10	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2022 - 10/2011
9	COVID-19 12/2021 - 12/2020
9	Inflammation (Inflammations) 01/2021 - 06/2007
8	Cardiovascular Diseases (Cardiovascular Disease) 10/2019 - 09/2002
7	Stroke (Strokes) 01/2018 - 04/2004
5	Hypertension (High Blood Pressure) 05/2022 - 12/2004
5	Ischemic Stroke 01/2012 - 01/2004
3	Delirium 07/2022 - 10/2013
3	Neoplasms (Cancer) 05/2022 - 01/2017
3	Heart Failure 05/2022 - 01/2006
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 11/2016
3	Infections 12/2020 - 11/2016
3	Chronic Disease (Chronic Diseases) 07/2020 - 12/2004
3	Disease Progression 07/2020 - 01/2014
3	Osteoporosis 01/2020 - 01/2014
3	Cerebrovascular Disorders (Cerebrovascular Occlusion) 10/2019 - 04/2008
3	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2019 - 12/2016
3	Atherosclerosis 01/2019 - 12/2016
3	Coronary Disease (Coronary Heart Disease) 01/2018 - 06/2007
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 04/2009
3	Insulin Resistance 01/2013 - 11/2010
2	Pneumonia (Pneumonitis) 07/2022 - 05/2022
2	Thrombosis (Thrombus) 11/2021 - 04/2016
2	ST Elevation Myocardial Infarction 11/2021 - 06/2017
2	Venous Thromboembolism 01/2021 - 01/2021
2	Abdominal Obesity 01/2021 - 04/2009
2	Pulmonary Embolism 01/2021 - 01/2021
2	Hyperglycemia 01/2021 - 01/2006
2	Type 2 Diabetes Mellitus (MODY) 07/2020 - 10/2014
2	Vascular Diseases (Vascular Disease) 01/2019 - 01/2017
2	Mixed Dementias 01/2018 - 12/2016
2	Gastroesophageal Reflux (GERD) 12/2017 - 12/2014
2	Anemia 08/2016 - 12/2006
2	Hyperlipoproteinemia Type III (Broad Beta Disease) 01/2015 - 11/2002
2	Hypercholesterolemia 01/2015 - 11/2002
2	Atrial Fibrillation 10/2011 - 01/2006
1	Pleurisy (Pleuritis) 07/2022
1	Skin Diseases (Skin Disease) 07/2022
1	Communicable Diseases (Infectious Diseases) 05/2022
1	Orthostatic Hypotension (Postural Hypotension) 05/2022
1	Vitamin D Deficiency 05/2022
1	Amyloidosis 01/2022
1	Diabetes Mellitus 01/2022
1	Lewy Body Disease (Lewy Body Dementia) 01/2022

Drug/Important Bio-Agent (IBA)

9	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2016
8	Aryldialkylphosphatase (Paraoxonase)IBA 01/2022 - 09/2002
8	Proteins (Proteins, Gene)FDA Link 08/2021 - 01/2011
7	EnzymesIBA 11/2021 - 12/2016
6	arylesteraseIBA 01/2022 - 06/2015
6	AntioxidantsIBA 07/2020 - 05/2013
6	CholesterolIBA 01/2019 - 03/2004
4	Interleukin-6 (Interleukin 6)IBA 12/2021 - 06/2007
4	HDL CholesterolIBA 01/2021 - 06/2007
4	Uric Acid (Urate)IBA 10/2019 - 01/2009
4	C-Reactive ProteinIBA 01/2018 - 04/2009
4	oxidized low density lipoproteinIBA 01/2017 - 11/2002
3	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2022 - 01/2020
3	HDL LipoproteinsIBA 05/2021 - 12/2016
3	LipidsIBA 01/2021 - 01/2018
3	Insulin (Novolin)FDA Link 01/2021 - 06/2007
3	Amyloid (Amyloid Fibrils)IBA 01/2020 - 06/2016
3	HomocysteineIBA 01/2018 - 02/2014
3	Biological ProductsIBA 08/2016 - 04/2011
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016 - 06/2007
2	ElectrolytesIBA 07/2022 - 05/2022
2	fibrin fragment D (D-dimer)IBA 10/2021 - 01/2021
2	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 06/2021 - 09/2002
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 05/2021 - 05/2020
2	Triglycerides (Triacylglycerol)IBA 01/2021 - 10/2014
2	LDL CholesterolIBA 01/2021 - 01/2015
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 01/2019
2	CytokinesIBA 01/2021 - 01/2017
2	Adenosine Triphosphate (ATP)IBA 01/2020 - 04/2009
2	Lipoproteins (Lipoprotein)IBA 01/2019 - 01/2018
2	Ceruloplasmin (Ferroxidase)IBA 01/2018 - 06/2015
2	Apolipoproteins E (ApoE)IBA 01/2018 - 09/2002
2	IronIBA 01/2018 - 01/2006
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 04/2017 - 01/2012
2	Cytokine Receptor gp130IBA 01/2017 - 11/2010
2	Antipsychotic Agents (Antipsychotics)IBA 09/2016 - 03/2005
2	VitaminsIBA 04/2016 - 06/2015
2	LigandsIBA 01/2016 - 01/2013
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2015 - 11/2002
2	Sulfhydryl Compounds (Thiols)IBA 02/2014 - 05/2013
2	Advanced Oxidation Protein Products (AOPP)IBA 02/2014 - 05/2013
2	Gonadal Steroid Hormones (Sex Hormones)IBA 10/2013 - 04/2011
2	Testosterone (Sustanon)FDA Link 04/2011 - 04/2008
2	Serum AlbuminIBA 01/2006 - 12/2004
1	hydroxide ionIBA 05/2022
1	Malondialdehyde (Propanedial)IBA 05/2022
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2022

Therapy/Procedure

7	Therapeutics 01/2021 - 04/2004
5	Home Nursing (Nursing, Home) 01/2019 - 12/2004
4	Activities of Daily Living (ADL) 01/2018 - 12/2006
2	Percutaneous Coronary Intervention 06/2017 - 04/2017
1	Length of Stay 07/2022
1	Stents 11/2021